We conducted immunohistochemical (IHC) staining on tumor-infiltrating immunocytes within the high- and low-HOXC6 expression groups (n = 20) to explore the underlying mechanism of HOXC6 in CRC progression. This evidence concerns the gene HOXC6 and neoplasm.